RadNet, Inc.
Financials
Valuation Metrics
RadNet, Inc.'s Market Cap is $5.78B. At end of 2025 it was $5.36B. Ranked #1266 of 3,114 in US market (top 41%), #422 of 1,469 on NASDAQ (top 29%), #84 of 203 in Health Care Equipment & Services (top 41%) by Market Cap.
Investment Metrics(as of 2026-10-30)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $5.78B | US#1,266/3,114 Sec#84/203 |
| Revenue | $2.27B | US#1,348/3,114 Sec#87/203 |
| Net Income | $-21M | US—/3,114 Sec—/203 |
| Total Assets | $4.23B | US#1,551/3,114 Sec#73/203 |
| Net Assets | $1.10B | US#1,703/3,114 Sec#91/203 |
| Employees | 8,844 | US#927/3,114 Sec#70/203 |
| Value | ||
| P/B | 5.27x | US#2,236/3,114 Sec#134/203 |
| P/S | 2.55x | US#1,476/3,114 Sec#101/203 |
| EV/EBITDA | 21.45x | US#1,922/3,114 Sec#87/203 |
| FCF Yield | -1.01% | US—/3,114 Sec—/203 |
| Profitability | ||
| ROE | -1.93% | US#2,176/3,114 Sec#117/203 |
| ROA | -0.50% | US#2,270/3,114 Sec#123/203 |
| Op. Margin | 4.00% | US#2,056/3,114 Sec#112/203 |
| Revenue Growth | 18.92% | US#722/3,114 Sec#48/203 |
| Financial Health | ||
| Debt Ratio | 258.40% | US#1,988/3,114 Sec#165/203 |
| Total Debt | $2.18B | US#1,124/3,114 Sec#55/203 |
| FCF | $-58M | US#2,548/3,114 Sec#180/203 |
| Cash | $726M | US#845/3,114 Sec#43/203 |
| Current Ratio | 1.48x | US#1,681/3,114 Sec#149/203 |
| Net Debt/EBITDA | 4.32x | US#1,886/3,114 Sec#122/203 |
| Performance | ||
| 1Y Return | -3.43% | US#2,187/3,114 Sec#146/203 |
| 1M Return | 6.60% | US#1,931/3,114 Sec#157/203 |
| From 52W High | -14.39% | US#1,350/3,114 Sec#106/203 |
| 1Y MDD | -38.60% | US#1,853/3,114 Sec#111/203 |
| Trading | ||
| Volume | 428,434 shares | US#2,438/3,114 Sec#167/203 |
| Trading Value | $31M | US#1,891/3,114 Sec#130/203 |
| Per Share | ||
| EPS | $-0.27 | US—/3,114 Sec—/203 |
| BPS | $13.94 | US#1,584/3,114 Sec#87/203 |
Company Info
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretations of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.